NCT06328504View on ClinicalTrials.gov

Efficacy of Cashew Nut Protein Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

April 21, 2026

Study Completion Date

April 21, 2027

Conditions
Food Allergy
Interventions
COMBINATION_PRODUCT

Cashew immunotherapy

Following the building-up phase (up to 60 weeks), patients will receive a daily low dose of cashew flour (1200 mg cashew protein) mixed with well-tolerated fruit mousse for 3 months (12 +/- 3 weeks).

Trial Locations (1)

02-091

RECRUITING

Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER